Table 3 Characteristics of patients with and without SARS-CoV-2 on day 14
Variables | Positive (n = 24) | Negative (n = 163) | Z or χ2 | P value |
|---|---|---|---|---|
Age, years | 46.5(40.0–56.5) | 46.0(34.0–51.0) | 1.132 | 0.26 |
Male, n (%) | 17(70.8) | 126(77.3) | 0.486 | 0.49 |
Diabetes, n (%) | 2(8.3) | 6(3.7) | 1.106 | 0.27 |
T1, days | 290.0(258.5–321.3) | 315.0(266.0–352.0) | 1.737 | 0.08 |
T2, days | 270.0(221.5–291.8) | 275.0(234.0–317.0) | 0.998 | 0.32 |
Duration of fever, days | 2.0(0–4.0) | 1.0(0–3.0) | 0.537 | 0.59 |
Laboratory findings | ||||
ALT, U/L | 19.6(13.0–26.2) | 21.1(15.3–37.1) | 1.636 | 0.10 |
AST, U/L | 19.0(16.0–22.0) | 20.0(16.0–25.0) | 0.670 | 0.50 |
Glucose, mmol/L | 5.4(4.8–6.7) | 5.1(4.7–5.9) | 1.526 | 0.13 |
Creatinine, µmol/L | 75.8(55.9–82.7) | 69.0(58.5–76.9) | 1.539 | 0.12 |
Uric acid, µmol/L | 269.3(224.2–316.8) | 322.4(270.3–380.2) | 2.997 | < 0.01 |
CRP, mg/L | 6.8(3.4–11.1) | 3.9(1.8–9.6) | 1.695 | 0.09 |
Neutrophils, E + 09/L | 3.6(2.9–4.6) | 4.1(3.0–5.3) | 1.244 | 0.21 |
Lymphocytes, E + 09/L | 0.8(0.6–1.3) | 1.1(0.8–1.5) | 2.084 | 0.04 |
Platelets, E + 09/L | 193.5(161.3–222.5) | 209.0(179.0–252.0) | 1.810 | 0.07 |
CD4+T | 387.5(238.0–503.0) | 482.0(332.0–693.0) | 2.382 | 0.02 |
CD8+T | 291.0(162.5–384.0) | 346.0(220.0–495.0) | 2.094 | 0.04 |
B cells count | 11.4(7.8–16.2) | 11.8(7.9–16.2) | 0.215 | 0.83 |
CT findings | ||||
Unilateral pneumonia, n(%) | 6(25.0) | 7(4.3) | 13.865 | < 0.01 |
Bilateral pneumonia, n(%) | 1(4.2) | 5(3.1) | 0.081 | 0.57 |